The hemagglutination inhibition (HAI) test, which detects subtype-specific antibodies against hemagglutinin (HA), is commonly used for serologic diagnosis of influenza virus infection and for determination of susceptibility to influenza virus in epidemiologic and vaccine studies. Naturally occurring inhibitors of hemagglutination by influenza viruses present in the sera of humans and animals were first described by Francis in 1947 (7) . These substances act like antibody in an HAI test by interacting with the influenza HA and thus preventing agglutination of erythrocytes (RBCs) by the virus. Three known classes of inhibitors, designated alpha, beta, and gamma, have been detected in human sera (9) . The properties and nature of these inhibitors have been described elsewhere (3, 9, 12) .
It is desirable to remove the activity of these inhibitors of hemagglutination from serum specimens because they make it difficult to use the HAI test to accurately assess HAspecific antibody in sera. A variety of techniques to inactivate serum inhibitors have been developed. These include treatment with heat, receptor-destroying enzyme (RDE) of Tibrio cholerae, trypsin, periodate, or a combination of these factors (6) . Each treatment method inactivates one or more classes of inhibitors (8, 12) . The effects of various methods of inactivating inhibitors in sera of humans and several animal species have been compared, but no single treatment method was found to be effective against all virus strains tested (2) . Another approach to measurement of serum HAI antibodies in the presence of inhibitors is to use an inhibitor-resistant influenza virus strain in the HAI test (6) . This approach has not c Rise in titer (log2) was the log2 mean of the ratios of postinfection to preinfection titers of data from Table 3 .
periodate treatments. The procedures used for treatment used as the antigen, we found that trypsin-periodate treatwith RDE, periodate, and combined trypsin and periodate ment was most effective in inactivating serum inhibitors. The were as described previously (6) . Serial twofold dilutions of titers obtained in sera from each of the 10 subjects following the treated sera, from 1:10 to 1:1,280, were tested in a this treatment were in the range (<1:10) that would be standard HAI test with 4 by kinetic enzyme-linked immunosorbent assay (13) . The geometric mean HAI antibody titers, the mean rise in titer, and the frequency of HAI titer rises are presented in Table 3 . The mean postinfection titer and mean rise in titer detected in HAI tests using the A/LA/2/87 parent virus were greater than those detected in assays using the inhibitor-resistant viruses. The A/LA/2/87 parent virus also detected more fourfold rises than any of the inhibitor-resistant viruses. The A/LA.HSPS.BB and A/LA.HSPSRS viruses failed to detect any titer rises. Similar results were obtained with RDEtreated sera. The log2-fold rise in titer against the individual inhibitorresistant viruses correlated with the frequency with which a panel of nine monoclonal antibodies reacted with the inhibitor-resistant mutants (Table 1 ). These results indicated that an HAI assay using the A/LA/2/87 inhibitor-sensitive parent virus and enzymatically or chemically treated sera was the most sensitive method for measurement of HAI antibodies and detection of titer rises.
The findings in the present study indicated that the inhibitor-resistant mutant viruses were not efficient for detecting rises in HAI antibody titer. There are several possible explanations for the lack of sensitivity of the inhibitorresistant viruses in detecting HAI titer rises in the volunteers infected with the A/LA/2/87 virus. First, the mutations in the viruses that resulted in the inhibitor-resistant phenotype occurred in or near the antibody-binding regions of the HA, thereby altering the antigenicity of the HA and rendering them less capable of detecting HA antibodies. The mutations in the inhibitor-resistant strains have been identified (Table  1) and are localized to the area of the HA molecule in and around the receptor-binding site (12) . Several antigenic changes in the HA were noted when these viruses were tested against a panel of anti-HA monoclonal antibodies, and it is possible that amino acid substitutions in and around the HA receptor-binding site could alter binding between antibodies and HA directly or indirectly by changing the conformation of the HA (12) . There was a strong inverse correlation (r = 0.94) between the loss of reactivity with anti-HA monoclonal antibodies and a rise in antibody titer detected in infected volunteers when the inhibitor-resistant mutants were used. This suggests that altered antigenicity of the HA in the inhibitor-resistant viruses contributed significantly to the inability of the HA to detect a rise in antibody titer in infected volunteers. However, it is still somewhat surprising that the inhibitor-resistant strains were also not efficient in detecting a polyclonal HAI antibody response. The naturally occurring A/Eng/42/72 virus had substitutions in each of the five antigenic sites of the H3 HA but was only four-to eightfold different from the original H3 prototype strain A/NT/68 in an HAI assay (4) . The inhibitor-resistant strain A/LA.PS used in our study appears to show a difference in the HAI test of a similar magnitude despite having sustained only one amino acid substitution (Table 1) . While the amino acid substitutions in the inhibitor-resistant strains could have had a global effect on the HA structure, this seems unlikely in view of the data on the crystal structure of a receptor-binding mutant HA, which suggests that the structural changes are of a local nature (15) .
Second, it is possible that the antigenic site-specific responses of the volunteers infected with the A/LA/2/87 wildtype virus were highly restricted and were localized to the sites bearing amino acid changes in the HA of mutant viruses. Such a restricted response in each of 16 individuals seems unlikely, especially for a secondary antibody response, which would be expected to be broad (5, 14) . A The choice of the ideal method for treating sera to inactivate inhibitors depends on the nature of inhibitor present and the virus. The results of this study indicate that the inhibitors present in our subjects were not beta inhibitors, because heating alone did not inactivate them. The ability of trypsinperiodate and RDE to inactivate them suggests that they belong to either the alpha or the gamma class of inhibitors. We can conclude from this study that combined chemical or enzymatic methods are effective for inactivating the widely prevalent inhibitors against currently circulating H3 HA. The use of inhibitor-resistant virus strains as a source of antigen in HAI tests is not recommended for these H3N2 viruses because of their decreased ability to detect antibodies specific to the HA.
